3 completed, 1 not yet recruiting. 2 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 2 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Uterine Endometrial Cancer: new trials by email Literature Review of Uterine Endometrial Cancer trials Research Report on Uterine Endometrial Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy TUB-040 - Dose escalation, TUB-040 - RP2D - Uterine Endometrial Cancer | Phase 1 / Phase 2 | Not yet recruiting | Gilead Sciences | 100 | 2026-10-01 | 2026-08-05 |
| A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers Ovarian Cancer, Fallopian Tube Cancer | Completed | Duke University | 47 | 2016-06-01 | 2022-02-11 | |
| A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers Pembrolizumab - Gynecologic Neoplasms, Epithelial Ovarian Cancer | Early Phase 1 | Completed | AA Secord | 39 | 2016-06-01 | 2024-02-21 |
| Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study Laparotomy, intravenous narcotics, standard anesthesia - Cervical Cancer, Uterine Endometrial Cancer | Early Phase 1 | Completed | Masonic Cancer Center, University of Minnesota | 103 | 2013-01-01 | 2020-02-17 |
Endometrial Neoplasms (4) · Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2) · Carcinoma, Ovarian Epithelial (1) · Genital Neoplasms, Female (1) · Uterine Cervical Neoplasms (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Neoplasms (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Uterine Diseases (4) · Uterine Neoplasms (4) · Adnexal Diseases (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Genital Neoplasms, Female (3) · Gonadal Disorders (3)
Anesthesia, Conduction (1) · Anesthesia, General (1) · Anesthesia, Local (1) · Anti-Inflammatory Agents, Non-Steroidal (1) · Laparotomy (1) · Morphine (1) · pembrolizumab (1)
AA Secord (1) · Duke University (1) · Gilead Sciences (1) · Masonic Cancer Center, University of Minnesota (1)
United States (4)
Angeles A Secord, MD (2) · Peter Argenta, M.D. (1)
K12HD043446 (1)